top of page

Media Appearances & Publications

Expanding Clinical Trial Access Amid DEI Challenges

Karen Winkfield, MD, PhD

March 2, 2025

Addressing the importance of clinical trial and the challenges of inclusive participation.

For-InternetAndSocialMedia-Winston-Salem-Raleigh-Durham-Headshots-Dr-Winkfield-3-2.jpg

National Expert to Speak on Improving access to quality Cancer Care.

Dr. Karen Winkfield discuss innovative strategies to improve access to quality cancer care at the 2025 Allen and Lee-Hwa Chao Lecture in Cancer Research.

February 17, 2025

2024 Healio Disruptive Innovators Award Recipient

Dr. Karen Winkfield, MD PhD.

This award goes to a physician who has made meaningful change to overcome the social determinants of health in hematology/oncology. The awardee models the ideals of health equity and demonstrates how identifying and addressing social determinants of health can improve patient care.

Social Determinants of Health in Cancer

with Dr. Karen Winkfield

by ViralEd CME Podcenter

Dr. Reggie Tucker-Seeley and Dr. Karen Winkfield discuss advocacy and healthcare delivery system issues in addressing SDOH in cancer care. 

00:00 / 36:49

Karen Winkfield, MD says pandemic caused ’80 percent reduction’ in cancer screening rates

“We know that there was a lot of fear about getting screens done during the COVID pandemic. In fact, access was restricted… some of the screening facilities… were closed during the initial part of COVID. So there are estimates that for some cancers that we can screen for– we can screen for about six different cancers–that there are some estimates about 80 percent reduction in terms of the screening rates.”

Disparities in Access and Health Care with Karen Winkfield

National Cancer Prevention Workshop

Karen Winkfield, MD says pandemic caused ’80 percent reduction’ in cancer screening rates

“We know that there was a lot of fear about getting screens done during the COVID pandemic. In fact, access was restricted… some of the screening facilities… were closed during the initial part of COVID. So there are estimates that for some cancers that we can screen for– we can screen for about six different cancers–that there are some estimates about 80 percent reduction in terms of the screening rates.”

Panel: Disparities in Cancer Care | Changing the Odds: The Hill's Cancer Summit

The Hill’s Steve Clemons in conversation with Dr. Gerald Harmon (President, American Medical Association) and Dr. Karen Winkfield (Ingram Professor of Cancer Research, Vanderbilt-Ingram Cancer Center; Executive Director, Meharry-Vanderbilt Alliance) Changing the Odds: The Hill's Cancer Summit, streamed on October 6, 2021. Sponsored by Illumina.

Bridging the Cancer Center Mission with Community Engagement

Stanford Cancer Institute

Disclaimer

Dr. Karen Winkfield provides on-line Internet information as a benefit to the public.
·     This service is provided for informational purposes only. It is not intended to replace consultation with a physician or other qualified health-professional.
·     Dr. Karen Winkfield cannot answer specific health questions on-line; however, general answers will be provided to appropriate questions raised by community participants. This information is not intended to be used diagnostically or therapeutically by the person(s) inquiring about said information.
·     It is understood that the information provided on this website is not a substitute for formal evaluation and discussion with a licensed clinician.
·     Resources listed, quoted, and individual (guest) articles, etc. and their authors, or links to other websites, do not necessarily support all or any of the views held by Dr. Karen Winkfield.
·      Although the Web provides a great deal of information on a variety of topics and subjects, Dr. Karen Winkfield recommends that you seek professional consultation to ensure your questions are adequately answered and an appropriate treatment plan outlined, if necessary.

Connect with Me

I am a:

Thanks for submitting!

© 2020 by Winkz Productions, LLC

bottom of page